During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

Although invasive cervical cancer may be suspected by inspection ... should be limited to patients with suspected invasive carcinoma on cervical biopsy, where conization may prove a frankly ...

compatible with the clinical cervical carcinoma FIGO stage IB 1. Because the patient chose to terminate the pregnancy, a radical hysterectomy with the fetus in situ, with ovarian preservation and ...

Menopause marks the end of a woman’s childbearing years, but it doesn’t mark the end of the need for a particular screening ...

Almost all cases are caused by human papillomavirus (HPV) infection, with approximately 80% classified as squamous cell carcinoma (SCC); the remainder are largely adenocarcinomas. Cervical cancer ...

Development of cervical cancer is a stepwise process by which localised cervical intra-epithelial neoplasia develops in the cervix and progresses into invasive and metastatic carcinoma forms. Growing ...

Agilent Technologies Inc. (NYSE: A) today announced its PD-L1 IHC 22C3 pharmDx (Code SK006) assay has received European IVDR ...

The PD-L1 IHC 22C3 PharmDx (Code SK006) assay is now certified for use to aid treatment decisions for patients with gastric or gastroesophageal junction adenocarcinoma.